Enhanced Tendon-to-Bone Healing via IKKβ Inhibition in a Rat Rotator Cuff Model
BACKGROUND: More than 450,000 rotator cuff repairs are performed annually, yet healing of tendon to bone often fails. This failure is rooted in the fibrovascular healing response, which does not regenerate the native attachment site. Better healing outcomes may be achieved by targeting inflammation during the early period after repair. Rather than broad inhibition of inflammation, which may impair healing, the current study utilized a molecularly targeted approach to suppress IKKβ, shutting down only the inflammatory arm of the nuclear factor κB (NF-κB) signaling pathway.
PURPOSE: To evaluate the therapeutic potential of IKKβ inhibition in a clinically relevant model of rat rotator cuff repair.
STUDY DESIGN: Controlled laboratory study.
METHODS: After validating the efficacy of the IKKβ inhibitor in vitro, it was administered orally once a day for 7 days after surgery in a rat rotator cuff repair model. The effect of treatment on reducing inflammation and improving repair quality was evaluated after 3 days and 2, 4, and 8 weeks of healing, using gene expression, biomechanics, bone morphometry, and histology.
RESULTS: Inhibition of IKKβ attenuated cytokine and chemokine production in vitro, demonstrating the potential for this inhibitor to reduce inflammation in vivo. Oral treatment with IKKβ inhibitor reduced NF-κB target gene expression by up to 80% compared with a nontreated group at day 3, with a subset of these genes suppressed through 14 days. Furthermore, the IKKβ inhibitor led to enhanced tenogenesis and extracellular matrix production, as demonstrated by gene expression and histological analyses. At 4 weeks, inhibitor treatment led to increased toughness, no effects on failure load and strength, and decreases in stiffness and modulus when compared with vehicle control. At 8 weeks, IKKβ inhibitor treatment led to increased toughness, failure load, and strength compared with control animals. IKKβ inhibitor treatment prevented the bone loss near the tendon attachment that occurred in repairs in control.
CONCLUSION: Pharmacological inhibition of IKKβ successfully suppressed excessive inflammation and enhanced tendon-to-bone healing after rotator cuff repair in a rat model.
CLINICAL RELEVANCE: The NF-κB pathway is a promising target for enhancing outcomes after rotator cuff repair.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:49 |
---|---|
Enthalten in: |
The American journal of sports medicine - 49(2021), 3 vom: 01. März, Seite 780-789 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Golman, Mikhail [VerfasserIn] |
---|
Links: |
---|
Themen: |
Biology of tendon |
---|
Anmerkungen: |
Date Completed 27.04.2021 Date Revised 02.03.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1177/0363546520985203 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM32069450X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM32069450X | ||
003 | DE-627 | ||
005 | 20231225174126.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1177/0363546520985203 |2 doi | |
028 | 5 | 2 | |a pubmed24n1068.xml |
035 | |a (DE-627)NLM32069450X | ||
035 | |a (NLM)33507808 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Golman, Mikhail |e verfasserin |4 aut | |
245 | 1 | 0 | |a Enhanced Tendon-to-Bone Healing via IKKβ Inhibition in a Rat Rotator Cuff Model |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.04.2021 | ||
500 | |a Date Revised 02.03.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: More than 450,000 rotator cuff repairs are performed annually, yet healing of tendon to bone often fails. This failure is rooted in the fibrovascular healing response, which does not regenerate the native attachment site. Better healing outcomes may be achieved by targeting inflammation during the early period after repair. Rather than broad inhibition of inflammation, which may impair healing, the current study utilized a molecularly targeted approach to suppress IKKβ, shutting down only the inflammatory arm of the nuclear factor κB (NF-κB) signaling pathway | ||
520 | |a PURPOSE: To evaluate the therapeutic potential of IKKβ inhibition in a clinically relevant model of rat rotator cuff repair | ||
520 | |a STUDY DESIGN: Controlled laboratory study | ||
520 | |a METHODS: After validating the efficacy of the IKKβ inhibitor in vitro, it was administered orally once a day for 7 days after surgery in a rat rotator cuff repair model. The effect of treatment on reducing inflammation and improving repair quality was evaluated after 3 days and 2, 4, and 8 weeks of healing, using gene expression, biomechanics, bone morphometry, and histology | ||
520 | |a RESULTS: Inhibition of IKKβ attenuated cytokine and chemokine production in vitro, demonstrating the potential for this inhibitor to reduce inflammation in vivo. Oral treatment with IKKβ inhibitor reduced NF-κB target gene expression by up to 80% compared with a nontreated group at day 3, with a subset of these genes suppressed through 14 days. Furthermore, the IKKβ inhibitor led to enhanced tenogenesis and extracellular matrix production, as demonstrated by gene expression and histological analyses. At 4 weeks, inhibitor treatment led to increased toughness, no effects on failure load and strength, and decreases in stiffness and modulus when compared with vehicle control. At 8 weeks, IKKβ inhibitor treatment led to increased toughness, failure load, and strength compared with control animals. IKKβ inhibitor treatment prevented the bone loss near the tendon attachment that occurred in repairs in control | ||
520 | |a CONCLUSION: Pharmacological inhibition of IKKβ successfully suppressed excessive inflammation and enhanced tendon-to-bone healing after rotator cuff repair in a rat model | ||
520 | |a CLINICAL RELEVANCE: The NF-κB pathway is a promising target for enhancing outcomes after rotator cuff repair | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a biology of tendon | |
650 | 4 | |a biomechanics of tendon | |
650 | 4 | |a growth factors/healing enhancement | |
650 | 4 | |a rotator cuff | |
650 | 4 | |a shoulder | |
650 | 7 | |a I-kappa B Kinase |2 NLM | |
650 | 7 | |a EC 2.7.11.10 |2 NLM | |
700 | 1 | |a Li, Xiaoning |e verfasserin |4 aut | |
700 | 1 | |a Skouteris, Dimitrios |e verfasserin |4 aut | |
700 | 1 | |a Abraham, Adam A |e verfasserin |4 aut | |
700 | 1 | |a Song, Lee |e verfasserin |4 aut | |
700 | 1 | |a Abu-Amer, Yousef |e verfasserin |4 aut | |
700 | 1 | |a Thomopoulos, Stavros |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The American journal of sports medicine |d 1993 |g 49(2021), 3 vom: 01. März, Seite 780-789 |w (DE-627)NLM000134392 |x 1552-3365 |7 nnns |
773 | 1 | 8 | |g volume:49 |g year:2021 |g number:3 |g day:01 |g month:03 |g pages:780-789 |
856 | 4 | 0 | |u http://dx.doi.org/10.1177/0363546520985203 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 49 |j 2021 |e 3 |b 01 |c 03 |h 780-789 |